Gene: Prame (preferentially expressed antigen in melanoma) Rattus norvegicus
Analyze
Symbol: Prame
Name: preferentially expressed antigen in melanoma
Description: Predicted to have retinoic acid receptor binding activity; predicted to be involved in several processes, including negative regulation of apoptotic process, negative regulation of cell differentiation, and negative regulation of retinoic acid receptor signaling pathway; predicted to localize to the cytoplasm; orthologous to human PRAMENP (PRAME N-terminal-like, pseudogene) and PRAME (preferentially expressed antigen in melanoma); INTERACTS WITH bisphenol A; 17beta-estradiol (ortholog); 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one (ortholog).
Type: protein-coding
RefSeq Status: MODEL
Also known as: LOC308656; LOC680000; melanoma antigen preferentially expressed in tumors; rCG38045-like; similar to preferentially expressed antigen in melanoma-like 3
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0X106,082,984 - 106,091,256 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0X105,969,013 - 105,977,129 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4X122,878,213 - 122,880,888 (+)NCBIRGSC3.4rn4RGSC3.4
CeleraX99,586,294 - 99,594,559 (-)NCBICelera
Cytogenetic MapXq32NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Prame
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1596887
Created: 2006-11-20
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.